login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
RALLYBIO CORP (RLYB) Stock News
USA
- NASDAQ:RLYB -
US75120L1008
-
Common Stock
0.6956
USD
-0.01 (-1.33%)
Last: 11/12/2025, 10:06:52 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RLYB Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Chartmill
RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline
6 days ago - By: Rallybio Corporation
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
20 days ago - By: Benzinga
- Mentions:
NBY
CYH
PMI
INBX
...
12 Health Care Stocks Moving In Thursday's After-Market Session
a month ago - By: Benzinga
- Mentions:
ENTA
ACHV
GNPX
KZR
...
12 Health Care Stocks Moving In Thursday's After-Market Session
2 months ago - By: Rallybio Corporation
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
2 months ago - By: Rallybio Corporation
Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program
3 months ago - By: Yahoo Finance
- Mentions:
RXRX
Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid
3 months ago - By: Rallybio Corporation
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates
4 months ago - By: Yahoo Finance
- Mentions:
RXRX
UBS
GMAB
Recursion Pharmaceuticals (RXRX) Rallies 8.7% on Hypophosphatasia
4 months ago - By: Yahoo Finance
- Mentions:
RXRX
Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
4 months ago - By: Yahoo Finance
- Mentions:
RXRX
Here's Why Shares in Recursion Pharmaceuticals Surged Today
4 months ago - By: The Motley Fool
- Mentions:
RXRX
Here's Why Shares in Recursion Pharmaceuticals Surged Today
4 months ago - By: Rallybio Corporation
Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals
5 months ago - By: Rallybio Corporation
Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
6 months ago - By: Rallybio Corporation
Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates
7 months ago - By: Rallybio Corporation
Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference
7 months ago - By: Yahoo Finance
- Mentions:
CALM
Trade policy changes alone won’t bring manufacturing back
7 months ago - By: Rallybio Corporation
Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT
8 months ago - By: Rallybio Corporation
Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
9 months ago - By: Rallybio Corporation
Rallybio to Present at the TD Cowen 45th Annual Health Care Conference
9 months ago - By: Rallybio Corporation
Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial
Please enable JavaScript to continue using this application.